APPLICATION
ANDA218668
TYPE
ANDA
ORIGINAL APPROVAL
2024-12-16
LATEST ACTION
2024-12-16
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
None (Tentative Approval), Prescription
Products
TOFACITINIB CITRATENone (Tentative Approval)
TOFACITINIB CITRATE 22MG · TABLET, EXTENDED RELEASE · ORAL
TOFACITINIB CITRATEPrescription
TOFACITINIB CITRATE EQ 11MG BASE · TABLET, EXTENDED RELEASE · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.